Atriplatrade mark - HIV therapy in one pill.

about

The Genetic Diversity and Evolution of HIV-1 Subtype B Epidemic in Puerto Rico Molecular Epidemiology of HIV-1 virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D and CRF-24BG.

P2860

Q36513021-60B2B7FA-AC97-4B3C-A509-255E3924E009 Q52586895-4A8A231E-2170-43D9-856A-9D53A1CE7E69

P2860

Atriplatrade mark - HIV therapy in one pill.

Item

http://www.wikidata.org/entity/Q36818184

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Atriplatrade mark - HIV therapy in one pill.

@en

type

Item

label

Atriplatrade mark - HIV therapy in one pill.

@en

prefLabel

Atriplatrade mark - HIV therapy in one pill.

@en

P1476

Atriplatrade mark - HIV therapy in one pill.

@en

P2093

Boris Julg

http://www.w3.org/2001/XMLSchema#string

Johannes R Bogner

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

Neuropsychiatric side effects of efavirenz therapy.

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.

Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.

Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies.

P304

573-577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18827852

http://www.w3.org/2001/XMLSchema#string

P932

2500249

http://www.w3.org/2001/XMLSchema#string

Atriplatrade mark - HIV therapy in one pill.

about

P2860

P2860

Atriplatrade mark - HIV therapy in one pill.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932